An Investigation of the Effects of Tiagabine on GABA using Magnetic Resonance Spectroscopy.

Trial Profile

An Investigation of the Effects of Tiagabine on GABA using Magnetic Resonance Spectroscopy.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Tiagabine (Primary)
  • Indications Anxiety; Epilepsy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Aug 2012 Accrual to date is 116% according to United Kingdom Clinical Research Network.
    • 25 Jul 2011 Status changed from recruiting to completed as reported by UKCRN.
    • 22 Jul 2011 United Kingdom Clinical Research Network reports accrual date changed from 66% to 166%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top